One of the most well-established approaches utilizes the Herpes Simplex Virus Thymidine Kinase (HSV-TK) gene, which phosphorylates the antiviral drug ganciclovir, converting it into a toxic compound that kills dividing tumor cells (30). Here, TKT is linked to neoplasm.